Crossmark

Comparison of inflammatory bowel disease relapse after top-down or step-up therapy: a population-based cohort study

Published Online: 2021-08-13

Published Print: 2021-10

Authors

Ochi, Masanori https://orcid.org/0000-0003-0850-6076
Niikura, Ryota https://orcid.org/0000-0001-5047-6195
Otsubo, Tetsuya https://orcid.org/0000-0001-7308-1989
Yamada, Atsuo https://orcid.org/0000-0003-4314-7777
Kawai, Takashi

Koike, Kazuhiko https://orcid.org/0000-0002-9787-1907
License Information

Text and Data Mining valid from 2021-08-13

Version of Record valid from 2021-08-13
More Information

Article History

Accepted: 5 August 2021

First Online: 13 August 2021

Declarations

:

: The University of Tokyo Hospital Institutional Review Board approved the study (2058–2). The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

: The University of Tokyo Hospital Institutional Review Board waived the requirement for patient informed consent because we used anonymized data.

: The authors declare no competing interests.

Document is current